3rd Quarter - Report

PREMIER, INC. for PREMIER, INC.

Firm
Client
Income
—
Expenses
$350,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA Reauthorization Act of 2017 (H.R. 2430) Overdose Prevention and Patient Safety Act (H.R. 3545) Protecting Jessica Grubbs Legacy Act (S. 1850) Prescription Drug Price Transparency Act (H.R. 1316) FAST Generics Act of 2017 (H.R.2051) CREATES Act of 2017 (H.R.2212/S.974) Medicare Home Infusion Therapy Access Act of 2017 (S. 1738)/ Section 101 of Medicare Part B Improvement Act of 2017 (H.R. 3178) Prescription Drug Price Transparency Act (MAC bill) (H.R.1316) Improving Transparency and Accuracy in Medicare Part D Spending Act (H.R.1038/S.413) Ensuring Seniors Access to Local Pharmacies Act of 2017 (H.R.1939/S.1044) Pharmacy and Medically Underserved Areas Enhancement Act (H.R.592/S.109) Patient Protection and Affordable Care Act (P.L. 111 - 148), Sec. 2551. Disproportionate share hospital payments (as modified by sec. 10201 and sec. 1203 of the Health Care and Education Reconciliation Act of 2010)

LobbyistCovered position, as disclosed
BLAIR GORDON CHILDS —
DUANNE PEARSON —
MARGARET REAGAN —
SHARA SIEGEL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1316 (115th), S. 413 (115th), H.R. 3178 (115th), H.R. 2212 (115th), H.R. 1939 (115th), S. 1738 (115th), H.R. 1038 (115th), H.R. 592 (115th), S. 109 (115th), H.R. 2051 (115th), S. 1850 (115th), H.R. 2430 (115th), S. 1044 (115th), H.R. 3545 (115th), S. 974 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.